HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART

Shelli F. Farhadian, Ofir Lindenbaum, Jun Zhao, Michael J. Corley, Yunju Im, Hannah Walsh, Alyssa Vecchio, Rolando Garcia-Milian, Jennifer Chiarella, Michelle Chintanaphol, Rachela Calvi, Guilin Wang, Lishomwa C. Ndhlovu, Jennifer Yoon, Diane Trotta, Shuangge Ma, Yuval Kluger, Serena Spudich

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

People with HIV (PWH) on antiretroviral therapy (ART) experience elevated rates of neurological impairment, despite controlling for demographic factors and comorbidities, suggesting viral or neuroimmune etiologies for these deficits. Here, we apply multimodal and cross-compartmental single-cell analyses of paired cerebrospinal fluid (CSF) and peripheral blood in PWH and uninfected controls. We demonstrate that a subset of central memory CD4+ T cells in the CSF produced HIV-1 RNA, despite apparent systemic viral suppression, and that HIV-1-infected cells were more frequently found in the CSF than in the blood. Using cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq), we show that the cell surface marker CD204 is a reliable marker for rare microglia-like cells in the CSF, which have been implicated in HIV neuropathogenesis, but which we did not find to contain HIV transcripts. Through a feature selection method for supervised deep learning of single-cell transcriptomes, we find that abnormal CD8+ T cell activation, rather than CD4+ T cell abnormalities, predominated in the CSF of PWH compared with controls. Overall, these findings suggest ongoing CNS viral persistence and compartmentalized CNS neuroimmune effects of HIV infection during ART and demonstrate the power of single-cell studies of CSF to better understand the CNS reservoir during HIV infection.

Original languageEnglish
Article numbere160267
JournalJCI insight
Volume7
Issue number13
DOIs
StatePublished - 8 Jul 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022, Farhadian et al.

Funding

We gratefully acknowledge the HARC research participants, the HARC study team, the Yale New Haven Hospital virology lab, and the late Kevin Robertson. Funding was provided by NIH K23 MH118999 (SFF), R21MH118109 (SS), R01MH125737 (SS), R01GM131642 (YK), American Federation for Aging Research (SFF), the Patterson Trust (SFF), the Doris Duke Charitable Foundation (SFF), NIH T32AG019134 (SFF), and the Yale Pepper Center (P30AG02134). LCN is supported in part by grant numbers NIH R01AG063846, UM1AI164559, and U01DA53625. This publication was made possible in part by the Fund to Retain Clinical Scientists at Yale, sponsored by the Doris Duke Charitable Foundation award 2015216, and the Yale Center for Clinical Investigation.

FundersFunder number
Patterson Trust
Yale Pepper CenterR01AG063846, P30AG02134, 2015216, U01DA53625
National Institutes of HealthR01MH125737, R01GM131642, R21MH118109, K23 MH118999
National Institute of Allergy and Infectious DiseasesUM1AI164559
Doris Duke Charitable FoundationT32AG019134
AMERICAN FEDERATION FOR AGING RESEARCH
Severns Family Foundation
Yale Center for Clinical Investigation, Yale School of Medicine

    Fingerprint

    Dive into the research topics of 'HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART'. Together they form a unique fingerprint.

    Cite this